Lower Cardiac Output Linked to Faster Brain Atrophy in Alzheimer's Risk Carriers

Researchers at Vanderbilt Health have made a significant discovery in the ongoing battle against Alzheimer's disease. A longitudinal study, involving investigators from the Vanderbilt Memory and Alzheimer's Center (VMAC), has revealed a crucial link between lower cardiac output and accelerated cerebral atrophy in older adults who carry the APOE-e4 allele. This genetic risk factor is known to increase the likelihood of developing Alzheimer's disease, and the findings of this study could have important implications for the prevention and treatment of the condition.

The study, which followed older adults over time, found that those with lower cardiac output experienced more rapid deterioration of the brain, as measured by cerebral atrophy. This suggests that maintaining healthy cardiovascular function may be essential for preserving brain health in individuals at risk of Alzheimer's disease. The APOE-e4 allele is a genetic variant that affects the brain's ability to clear amyloid beta, a protein that accumulates in the brains of people with Alzheimer's disease. The study's findings highlight the complex interplay between cardiovascular health and brain function, and underscore the need for further research into the relationship between these two critical systems.

The discovery of this link between cardiac output and cerebral atrophy in individuals with the APOE-e4 allele offers new avenues for investigation into the prevention and treatment of Alzheimer's disease. By identifying modifiable risk factors, such as cardiovascular health, researchers may be able to develop more effective strategies for reducing the risk of cognitive decline and dementia. Further research is needed to confirm these findings and to explore the potential benefits of cardiovascular interventions for individuals at risk of Alzheimer's disease.